With only 10% of the human genome representing druggable targets, and only half of those being relevant to disease, it is important to be able to predict how druggable a novel target is in early ...
In the past years, the pharmaceutical and biotech industries have been alarmed by the fact that as low as 3,000 druggable targets may be present in the human genome 13. Given the high level of ...